Risk of Business Activity Stagnation Due to COVID-19
First written in FY2020. 12 of 14 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2025ReframedAnnual report
「The cement industry is capital-intensive, and production relies on a large number of operating personnel. If the Group is unable to secure sufficient operating personnel due to occupational accidents or infectious diseases, this may have a material impact on the Group.」
The risk assessment was broadened from the risk of business disruptions caused specifically by COVID-19 to the risk of being unable to secure operating personnel due to health and safety issues or infectious diseases. - FY2024RestatedAnnual report
「If the spread of infectious diseases such as viruses results in restrictions on activities at the Group's domestic and overseas offices, manufacturing sites and other facilities, this may lead to production suspensions, disruptions to sales, logistics and procurement functions, and an impact on business performance.」
The risks of disruptions to manufacturing, sales, logistics and procurement functions due to an infectious disease outbreak, and measures such as working from home when an outbreak occurs, have been reconfirmed. - FY2023-Q3RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease on business performance will be limited, and the absence of material changes from the previous year, have been reconfirmed. - FY2023-Q2RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease on business performance will be limited, and the absence of material changes from the previous year, have been reconfirmed. - FY2023-Q1RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease on business performance will be limited, and the absence of material changes from the previous year, have been reconfirmed. - FY2022RestatedAnnual report
「If the spread of infectious diseases such as viruses results in restrictions on activities at the Group's domestic and overseas offices, manufacturing sites and other facilities, this may lead to production suspensions, disruptions to sales, logistics and procurement functions, and an impact on business performance.」
The risks of disruptions to manufacturing, sales, logistics and procurement functions due to an infectious disease outbreak, and measures such as working from home when an outbreak occurs, have been reconfirmed. - FY2022-Q3RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease on business performance will be limited continues to be applied, and it is stated that there have been no material changes from the previous year. - FY2022-Q2RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease on business performance will be limited continues to be applied, and it is stated that there have been no material changes from the previous year. - FY2022-Q1RestatedAnnual report
「Accounting estimates, including impairment of fixed assets, are being made on the assumption that the impact of the spread of COVID-19 on the Group's business performance will be limited and will not have a significant impact going forward. Accordingly, there have been no material changes to the assumptions described in the "Additional Information (Accounting Estimates Related to the Spread of COVID-19)" section of the previous consolidated fiscal year's annual securities report.」
The accounting assumption that the impact of the infectious disease will be limited continues to be applied, and it is stated that there have been no material changes from the previous year. - FY2021RestatedAnnual report
「If the spread of infectious diseases such as viruses results in restrictions on activities at the Group's domestic and overseas offices, manufacturing sites and other facilities, this may lead to production suspensions, disruptions to sales, logistics and procurement functions, and an impact on business performance. In addition, if economic and production activity stagnates in Japan and overseas, shipments are expected to decline due to production cutbacks, stoppages and inventory adjustments, depending on conditions at shipping destinations.」
The risk of disruptions to manufacturing, sales, logistics and procurement functions due to an infectious disease outbreak has been reconfirmed, along with measures such as, in principle, switching to remote work when an outbreak occurs. - FY2021-Q3RestatedAnnual report
「Regarding the outlook for COVID-19, although economic conditions are showing signs of recovery, there are concerns that the impact of COVID-19 may be prolonged. Accounting estimates, including impairment accounting for fixed assets and the recoverability of deferred tax assets, are being made on the assumption that this trend will continue during the current consolidated fiscal year.」
Accounting estimates continue to be made on the assumption that the impact of the infectious disease will be prolonged, and it is stated that there have been no material changes to the assumptions disclosed in the previous fiscal year's annual securities report. - FY2021-Q2RestatedAnnual report
「Given concerns that the impact of COVID-19 may be prolonged, accounting estimates, including impairment accounting for fixed assets and the recoverability of deferred tax assets, are being made on the assumption that this trend will continue during the current fiscal year.」
Accounting estimates continue to be made on the assumption that the impact of the infectious disease will be prolonged. No material changes have been made to the assumptions disclosed in the previous fiscal year's annual securities report. - FY2021-Q1RestatedAnnual report
「In the cement industry, domestic cement demand declined to 9,398 thousand tonnes, down 6.3% from the same period of the previous year, due to the peaking of demand related to earthquake reconstruction and the Hokuriku Shinkansen, delays in redevelopment projects in urban areas, and the impact of construction work being suspended at some sites following the spread of the novel coronavirus disease, resulting in declines in both public-sector and private-sector demand.」
The impact of construction suspensions due to COVID-19 and declining domestic demand continues this quarter. No new risks have arisen and there have been no material changes from the information disclosed for the previous fiscal year. - FY2020First statedAnnual report
「Due to the impact of the novel coronavirus disease, domestic sales in the cement-related business have remained weak recently, partly because of suspended construction work. Exports have also been affected by lower sales due to lockdowns in some regions, and plants have responded with partially curtailed operations and other measures. The high-performance products business has also been partly affected by stagnant economic and production activity in Japan and overseas.」
Weak domestic sales, lower exports, curtailed plant operations, and the impact on high-performance product sales due to the infectious disease outbreak were independently disclosed for the first time as risks that had actually materialized.